Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

RESEARCH ON CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL)

In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only, should never be considered medical advice, and should never be acted on without review with your health care team.

WOULD YOU LIKE TO PARTICIPATE IN 
A DISCUSSION ABOUT CLL / SLL?  

GLOBAL PATIENTS IS RECRUITING PARTICIPANTS TO TAKE PART IN A ONE-ON-ONE INTERVIEW ABOUT CLL / SLL.

What is the study about? 

The purpose is to understand patients’ experiences with chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL), and to learn about symptoms, treatment burden, treatment decisions, treatment outcomes, and how these may impact patient quality of life.

What is involved?

  • Participate in a one-on-one  90-minute interview by phone/online using MS Teams 
  • Complete a short online questionnaire

What is needed?

  • Participants must have sufficient knowledge about their current and previous medications for CLL / SLL in order to be eligible.
  • If interested, potential participants are encouraged to contact their treating physician or clinic to obtain information about their current and previous medications related to CLL / SLL prior to the screening process.

Will there be any compensation?

Participants will be reimbursed  $150 USD for their time.

For more information, or if interested, please contact [email protected]

CLL Society - Living With CLL
RECENT NEWS

When appropriate, the CLL Society will be posting updates and background information on the present Coronavirus pandemic focusing on reliable primary sources of information and avoiding most of the news that is not directly from reliable medical experts or government and world health agencies.